Barely Significant
← all excerpts

Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review.

Ir J Med Sci · 2023 · PMC9463664 · PMID 36087236

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantp value < 0.01actually significant
This was highly significant in sero-negative patients (median: 14 days vs. 27 days; p value < 0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.